The Drug Effectiveness Review Project: An Important Step Forward
- 1 January 2006
- journal article
- editorial
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 25 (Suppl1) , W272-W275
- https://doi.org/10.1377/hlthaff.25.w272
Abstract
Peter Neumann's paper on the Drug Effectiveness Review Project (DERP) is a constructive if incomplete point of departure for discussing the work done by the project and the use of that work by decision-makers in states and elsewhere. This Perspective attempts to establish the proper context for judging the DERP by comparing its product and processes with those commonly produced and used by industry and other parties. It also provides a direct response to the criticisms of the project noted by Neumann.Keywords
This publication has 6 references indexed in Scilit:
- Bias in published cost effectiveness studies: systematic reviewBMJ, 2006
- Health Industry Practices That Create Conflicts of InterestJAMA, 2006
- Emerging Lessons From The Drug Effectiveness Review ProjectHealth Affairs, 2006
- Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysisInternational Clinical Psychopharmacology, 2005
- Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?BMJ, 2002
- Evidence based medicine: what it is and what it isn'tBMJ, 1996